| Financial Year |
March 31 2023 |
| Monetary Funds |
392,701,448.12 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
36,959,362.63 |
| Accounts Receivable |
1,389,691,574.17 |
| Advances to Suppliers |
2,812,742.95 |
| Other Receivables |
23,863,575.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
233,270,861.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
2,172,578,700.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
266,244,211.57 |
| Under-construction Projects |
17,835,001.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
32,233,758.16 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,776,105.29 |
| Deferred Income Tax Assets |
26,884,718.49 |
| Other Non-Current Assets |
7,598,464.92 |
| Sub-Total of Non-Current Assets |
358,108,078.95 |
| Total Assets |
2,530,686,779.57 |
| Short-Term Loans |
420,836,801.39 |
| Trading Financial liabilities |
-- |
| Notes Payable |
710,944,573.80 |
| Accounts Payable |
148,857,183.09 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,080,072.11 |
| Taxes Payable |
55,946,882.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
32,015,548.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
581,599.50 |
| Other Current Liabilities |
15,941,692.15 |
| Sub-Total of Current Liabilities |
1,414,918,518.75 |
| Long-term Loans |
30,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,639,463.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
39,079,608.78 |
| Total Liabilities |
1,453,998,127.53 |
| Paid-In Capital(Or Share Stock) |
161,649,410.00 |
| Capital Surplus |
494,778,959.92 |
| Surplus Reserve |
55,817,153.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
364,443,128.23 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,076,688,652.04 |
| Owner's Equity（Stockholder's Equity） |
1,076,688,652.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,530,686,779.57 |
